With the continuous development of pharmaceutical industry and increasingly various biological products, the market demands to high resolution chromatography resin is increasing. By virtue of its excellent separation and stable property, MaXtar® Q HR resin has been applied in clinical stage of antibody, vaccine and recombinant protein and marketed projects. This article will introduce its features and performances fully.

Figure 1. MaXtar® Q HR binding capacity performance between three batches
Summary: Using BSA standard protein to characterize the binding capacity of MaXtar® Q HR, there is no obvious differences between batches.
| Project | Phase | LRV |
| Project 1 | IND | >4 |
| Project 2 | Phase II | >5 |
Table 1. Virus-removal validation performance in different projects
01.Pressure flow rate curve

Figure 2. MaXtar® Q HR pressure flow rate curve
02.Production-scale Column Packing
| Column Specification | D=1200 H=21.5 cm |
| Column Efficiency HETP | 9471 |
| Symmetry AS | 1.01 |

Summary: MaXtar® Q HR is based on the MaXtar® high-flow improved agarose matrix. When the pressure reaches up to 3 bar, the linear flow rate is ≥ 300 cm/h, and it has been successfully applied in industrial production.
Case Share
Application 1
Sample Information: lgG

Figure 3. HCP removal and recovery rate performance of different anion
Summery: MaXtar® Q HR possesses both high recovery rate and excellent HCP removal capability in antibody projects. The HCP removal effect and recovery performance after IgG purification are better than those of other domestic manufacturers.
Application 2
Sample Information: Plasmid DNA
Volume of Column: H=15 cm, D=26 mm
Equilibrium Buffer: 100 mM Tris-HCl, 0.4 M NaCl 10 mM EDTA, pH 7.5
Elution Buffer: 100 mM Tris-HCl,1.0 M NaCl 10 mM EDTA, pH 7.5 (0-100%B,5 CV)

Figure 4. Plasmid DNA purification chromatogram
Summery: MaXtar® Q HR possesses excellent separation ability in plasmid projects. After linear elution, RNA residuals can be removed efficiently.
MaXtar® Q HR is widely used in recombinant protein and antibody projects. It mostly adopts the flow-through mode, and the main purpose is to remove exogenous impurities. In the early stage of process development, the optimization of loading pH and conductivity, as well as the loading amount, are the key parameters of the flow-through mode. With the help of DoE experiments, the optimal experimental conditions can be quickly found. In applications such as vaccines, MaXtar® Q HR mostly adopts the binding mode. In the early stage of process development, elution with salt concentration is given priority. If the sample cannot be effectively separated or the resolution is low, the salt concentration for elution can be appropriately extended. After the separation effect is achieved, the stepwise elution method can be optimized. If the loading capacity is low, the pH can be appropriately increased to enhance the ion interaction and improve the loading capacity.
Products Catalog Number
| Products Name | Cat. No. | Pack Size |
| MaXtar® Q HR | 1014-1811 | 25 mL |
| 1014-1812 | 100 mL | |
| 1014-1813 | 500 mL | |
| 1014-1814 | 1L | |
| 1014-1815 | 5 L | |
| 1014-1816 | 10 L | |
| 1014-1817 | 20 L | |
| Chrom-Trap® MaXtar® Q HR 1mL | 2014-1811 | 1×1 mL |
| Chrom-Trap® MaXtar® Q HR 4.7mL | 2014-1812 | 1×4.7 mL |
| Chrom-Trap® MaXtar® Q HR 5mL | 2014-1813 | 1×5 mL |
Link With Us Now!